1-4 of 4
Victoria A. Joshi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Impact of Initial Gefitinib or Erlotinib versus Chemotherapy on Central Nervous System Progression in Advanced Non–Small Cell Lung Cancer with EGFR Mutations

Stephanie Heon, Beow Y. Yeap, Neal I. Lindeman, Victoria A. Joshi, Mohit Butaney, Gregory J. Britt, Daniel B. Costa, Michael S. Rabin, David M. Jackman, Bruce E. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (16): 4406–4414.
https://doi.org/10.1158/1078-0432.CCR-12-0357
Published: 14 August 2012
View article titled, The Impact of Initial Gefitinib or Erlotinib versus Chemotherapy on Central Nervous System Progression in Advanced Non–Small Cell Lung Cancer with <em>EGFR</em> Mutations
Open the PDF for The Impact of Initial Gefitinib or Erlotinib versus Chemotherapy on Central Nervous System Progression in Advanced Non–Small Cell Lung Cancer with <em>EGFR</em> Mutations in another window
Journal Articles

Epidermal Growth Factor Receptor Mutation Testing in the Care of Lung Cancer Patients

Lecia V. Sequist, Victoria A. Joshi, Pasi A. Jänne, Daphne W. Bell, Panos Fidias, Neal I. Lindeman, David N. Louis, Jeffrey C. Lee, Eugene J. Mark, Janina Longtine, Peter Verlander, Raju Kucherlapati, Matthew Meyerson, Daniel A. Haber, Bruce E. Johnson, Thomas J. Lynch
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (14): 4403s–4408s.
https://doi.org/10.1158/1078-0432.CCR-06-0099
Published: 20 July 2006
View article titled, <em>Epidermal Growth Factor Receptor</em> Mutation Testing in the Care of Lung Cancer Patients
Open the PDF for <em>Epidermal Growth Factor Receptor</em> Mutation Testing in the Care of Lung Cancer Patients in another window
Journal Articles

Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib

David M. Jackman, Beow Y. Yeap, Lecia V. Sequist, Neal Lindeman, Alison J. Holmes, Victoria A. Joshi, Daphne W. Bell, Mark S. Huberman, Balazs Halmos, Michael S. Rabin, Daniel A. Haber, Thomas J. Lynch, Matthew Meyerson, Bruce E. Johnson, Pasi A. Jänne
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (13): 3908–3914.
https://doi.org/10.1158/1078-0432.CCR-06-0462
Published: 03 July 2006
View article titled, Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib
Open the PDF for Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib in another window
Journal Articles

A Rapid and Sensitive Enzymatic Method for Epidermal Growth Factor Receptor Mutation Screening

Pasi A. Jänne, Ana M. Borras, Yanan Kuang, Andrew M. Rogers, Victoria A. Joshi, Hema Liyanage, Neal Lindeman, Jeffrey C. Lee, Balazs Halmos, Elizabeth A. Maher, Robert J. Distel, Matthew Meyerson, Bruce E. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (3): 751–758.
https://doi.org/10.1158/1078-0432.CCR-05-2047
Published: 07 February 2006
View article titled, A Rapid and Sensitive Enzymatic Method for Epidermal Growth Factor Receptor Mutation Screening
Open the PDF for A Rapid and Sensitive Enzymatic Method for Epidermal Growth Factor Receptor Mutation Screening in another window